Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Government of Canada was posted on May 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Cervical Screening (CervixCheck) Self-Sampling Kits

Closed
SK-SSO-CL-0130International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413
New
Federal
6640--LAB - Immunochemistry (IHC) instrument
Solicitation # 36C24226Q0827
The Department of Veterans Affairs, through Network Contracting Office 2, intends to award a sole-source contract to Roche Diagnostics Corporation for proprietary reagent kits and consumables compatible with VA-owned Roche Benchmark Ultra Plus immunohistochemistry instruments. This action is justified under FAR 6.302-1 due to the technical exclusivity of the reagents, as no alternative suppliers can provide products that function with the existing VA equipment. The solicitation, identified by number 36C24226Q0827, was posted on July 22, 2026, with responses due by July 30, 2026, at 10:00 a.m. Eastern Time, submitted exclusively via email to the Contracting Officer, Aleta Jennette. The contract is for laboratory reagents essential to ongoing diagnostic operations, primarily at the James J. Peters VA Medical Center in Bronx, NY, though the final place of performance remains TBD. No competitive solicitation exists, and therefore no formal evaluation factors, pricing details, line items, or contract value have been established. The procurement is non-competitive, with no set-asides for small or socioeconomic businesses, and no socioeconomic certifications or UEI/CAGE codes for the vendor are provided. Packaging, marking, preservation, inspection, acceptance criteria, and invoicing methods are not specified, with assumed compliance to standard commercial practices for laboratory reagents. Contract administration oversight is limited to the Contracting Officer, with no designated COR, COTR, or PCO identified. The contracting office is located in Albany, NY, but administrative and performance functions are centered at the Bronx facility. No FAR clauses, special requirements, or representations from the offeror are included, as the document serves solely as a market research notice indicating intent to award without requiring formal proposals, quotes, or submissions other than expressions of interest. The acquisition is driven entirely by proprietary compatibility, with no alternatives available, rendering traditional contract elements such as pricing, delivery schedules, or payment terms unnecessary at this preliminary stage.
242-NETWORK Contract Office 02 (36C242)

POSTED

3 days ago

DEADLINE

in 4 days
NAICS: 325413
New
Federal
6550 - Molecular Diagnostic Laboratory Reagents (Kits)
Solicitation # 36C26026Q0957
The Department of Veterans Affairs, through the Network Contract Office 20, is seeking a vendor to provide molecular diagnostic laboratory reagent kits for the Microbiology Department at the VA Portland Health Care System in Oregon. The contract, identified by solicitation number 36C26026Q0957, covers the procurement of FDA-cleared multiplex PCR test kits compatible with VA-owned molecular analyzers. These kits must support the simultaneous detection of respiratory pathogens (up to 20 targets), gastrointestinal pathogens (at least 20 targets), blood culture identification (at least 40 targets), and meningitis/encephalitis targets (up to 14 targets). Technical requirements specify a self-contained system for amplification, detection, and analysis, requiring minimal hands-on setup time of two minutes or less and a total result turnaround time of one hour. The period of performance is scheduled from December 1, 2026, to November 30, 2031, structured as a base year followed by four option years. Specific line items include the BCID2, GI, and RP 2.1 panels. The procurement is categorized under NAICS code 325413 and is being conducted as a sources-sought effort without a specific set-aside. Performance will take place at the VA Portland Medical Center, with the primary point of contact being Eric Lingenfelter.
260-NETWORK Contract Office 20 (36C260)

POSTED

3 days ago

DEADLINE

in 21 days

AI Contract Overview

Show more

The Saskatchewan Cancer Agency, through 3sHealth, is seeking vendors to supply self-sampling test kits fully compatible with the BD COR™ System for use in Saskatchewan’s transition to HPV primary screening for cervical cancer. The procurement aims to meet both the immediate operational demands of the provincial program and its long-term sustainability for the population served. Vendors must submit twelve samples of each proposed kit option, delivered to the specified address in Regina by May 21, 2026, at no cost to the agency; failure to provide these samples will result in a non-responsive bid. The submitted samples will be evaluated as part of the technical assessment and are non-returnable. The solicitation, identified as SK-SSO-CL-0130, was posted on May 14, 2026, with proposals due by June 5, 2026, and falls under NAICS code 325413 for pharmaceutical and medicine manufacturing. All communications and inquiries must be directed to Lori Ann Litzenberger, the Contracting Authority.

General Info

Procurement of BD COR™ compatible self-sampling HPV test kits; samples due May 21, 2026; proposals by June 5, 2026.

Agency

Government of Canada → 3sHealth

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

Saskatchewan, CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → 3sHealth
Contacts1 person available
OfficeN/A
Organization / Agency
Government of Canada → 3sHealth
Office AddressN/A
Contacts
Lori Ann LitzenbergerContracting Authority

Full Description

Show more
The purpose of this Request for Proposal (RFP) is to procure self-sampling test kits that are fully compatible with the BD COR™ System laboratory equipment selected by Saskatchewan’s HPV Primary Screening Program. The Saskatchewan Cancer Agency (SCA) is seeking a product and vendor solution that meets the immediate operational requirements of the provincial transition to HPV primary screening, while also supporting the long-term needs of the Program and the population it serves. Additional InformationSamples: All Vendors must provide twelve (12) samples of each proposed option available to the SCA. All samples must be delivered and available on-site no later than May 21, 2026. Failure to provide the required samples may result in the Vendor being deemed non‑responsive. All samples shall be provided at no cost to the SCA and will be reviewed as part of the technical evaluation, contributing to the overall evaluation and scoring of proposals. Samples submitted will not be returned. Samples must be delivered to the address below: Harbour Landing Business Park Suite 200 – 4545 Parliament Avenue c/o Ada Bunko Regina, Saskatchewan S4W 0G3